Spurring private investment in health R&D around the world
Private investment in health R&D by pharmaceutical companies, charitable foundations, and venture capital firms, among others, can help to save lives and boost the health of entire regions. But some countries’ health governance infrastructures, management capacities, regulatory processes, and policy conditions are better equipped to utilize this private funding than others. What governance factors promote an investment-friendly environment for the private sector? And how can countries attract more private sector health financing?
On March 30, Governance Studies at Brookings hosted a panel of experts to discuss what conditions lead to good health governance and how those conditions affect a country’s ability to use private investments in health R&D. At the event, authors Darrell West and John Villasenor released their new paper, “Health governance capacity: Enhancing private sector investment in global health,” which examines 18 countries throughout Asia and sub-Saharan Africa. How compatible is each country’s health governance strategy with effective use of private investment in R&D?
Join the conversation at #GlobalHealth or @BrookingsGov.
Presentation of Results
Darrell M. West
Senior Fellow - Center for Technology Innovation
Douglas Dillon Chair in Governmental Studies
Nonresident Senior Fellow - Governance Studies, Center for Technology Innovation
Former Brookings Expert
Chief Operating Officer and Senior Fellow - Center for Global Development
President & Executive Director - Global Health Council
H.E. Pham Quang Vinh
Ambassador of Vietnam to the United States
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.